Dr. Agarwal’s Health Care Limited reported a strong financial and operational performance for the quarter and year ended March 31, 2026, crossing the Rs. 2,000 crore revenue milestone for the first time in its history. 

The company posted consolidated revenue from operations of Rs.2,080 crore in FY2026, marking a 21.6 percent year-on-year growth, while profit after tax surged 52.4 percent to Rs.168 crore.

For the quarter ended March 31, 2026, the company reported total income of Rs. 577 crore, up 21.2 percent year-on-year, while revenue from operations increased 22.6 percent to Rs. 564 crore. Revenue from India operations stood at Rs. 505 crore, registering a 22.1 percent growth, while revenue from mature facilities rose sharply by 30.5 percent to Rs. 420 crore.

Operationally, the company performed 84,962 surgeries during the quarter, reflecting a 23.6 percent year-on-year increase. EBITDA for the quarter stood at Rs.174 crore, up 18.9 percent, with EBITDA margins at 30.2 percent. Profit after tax for Q4 FY2026 rose 17.4 percent to Rs. 50 crore.

For the full year FY2026, total income increased 20.9 percent to Rs. 2,125 crore. Revenue from India operations grew 21.7 percent to Rs. 1,871 crore, while revenue from mature facilities climbed 35.3 percent to Rs. 1,632 crore. The company performed 323,245 surgeries during the year, registering a 14.5 percent growth over the previous fiscal.

EBITDA for FY2026 stood at Rs. 614 crore, reflecting a 22.2 percent increase, while EBITDA margins improved to 28.9 percent. Profit after tax margins stood at 7.9 percent for the year.

Dr. Adil Agarwal, CEO of Dr. Agarwal’s Health Care Limited, described FY2026 as a landmark year for the company. He said the company had achieved all the targets it set a year ago and entered FY2027 with strong momentum, expansion plans and a continued focus on clinical excellence and patient care.